Hinge Health is trading at $90.34, down 4.05%, amid weaker equities; no fresh company-specific catalyst has been identified.
- The Nasdaq Composite is down 0.78% as investors assess firmer yields, oil-market volatility, and cautious risk sentiment.
- Recent insider-sale reports cover transactions from September 10 and September 14 under prearranged plans, so they do not clearly explain the current move.